Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure

Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure

Objectives: To the best of our knowledge, data from Gemtuzumab ozogamicin in Acute Myeloid Leukemia (AML) patients with failure of organ functions and poor performance status are extremely lacking. Moreover, the fast recovery from organ failure, after Gemtuzumab ozogamicin administration, has never...

Full description

Bibliographic Details
Main Authors: Daniil Zaytsev, Larisa Girshova, Vladimir Ivanov, Irina Budaeva, Dmitri Motorin, Renat Badaev, Julia Mirolubova, Evgeni Grobovenko, Tamara Chitanava, Ekaterina Zaykova, Julia Alexeeva, Andrey Zaritskey
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Biology
Subjects:
acute myeloid leukemia
respiratory failure
kidney failure
organ dysfunction
gemtuzumab ozogamicin
Online Access:https://www.mdpi.com/2079-7737/9/2/28

Similar Items

Similar Items